481
Act on Supplementing § 76 of the Medicines Act
Introduced
13 June 2017
Last action
—
Status
AVALDATUD_RIIGITEATAJAS
Sponsors
—
Subjects
Discovery layer
Source updated
25 October 2017
Summary
The bill supplements the Medicines Act with a new provision, according to which the Agency of Medicines can declare the marketing authorization invalid if the drug is not available in Estonia from the holder of the marketing authorization for three consecutive years, except when it is necessary to keep the marketing authorization valid in the interests of public health.
Machine translation from Estonian. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
16 official files
Eelnõu pdf
Eelnõu pdf
pdf · ET · 11 June 2018
Lõpptekst bdoc
bdoc · ET · 3 November 2017
Lõpptekst
doc · ET · 3 November 2017
Vabariigi Presidendi otsus bdoc
bdoc · ET · 3 November 2017
Vabariigi Presidendi otsus
rtf · ET · 3 November 2017
Vastuvõetud seadus bdoc
bdoc · ET · 25 October 2017
Kaaskiri Vabariigi Presidendile
pdf · ET · 25 October 2017
Vastuvõetud seadus
pdf · ET · 25 October 2017
Eelnõu
docx · ET · 23 October 2017
Seletuskiri
docx · ET · 17 October 2017
Eelnõu
docx · ET · 17 October 2017
Seletuskiri
docx · ET · 12 September 2017
Eelnõu
docx · ET · 12 September 2017
Seletuskiri pdf
pdf · ET · 13 June 2017
Eelnõu docx
docx · ET · 13 June 2017
Seletuskiri docx
docx · ET · 13 June 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.